|
Feb 14
|
AtriCure Full Year 2024 Earnings: EPS Misses Expectations
|
|
Feb 13
|
AtriCure (ATRC) Upgraded to Buy: Here's What You Should Know
|
|
Feb 13
|
Q4 2024 AtriCure Inc Earnings Call
|
|
Feb 13
|
Is AnaptysBio (ANAB) Stock Outpacing Its Medical Peers This Year?
|
|
Feb 13
|
AtriCure Inc (ATRC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
|
|
Feb 12
|
Here's What Key Metrics Tell Us About AtriCure (ATRC) Q4 Earnings
|
|
Feb 12
|
AtriCure (ATRC) Reports Q4 Loss, Lags Revenue Estimates
|
|
Feb 12
|
AtriCure: Q4 Earnings Snapshot
|
|
Feb 12
|
AtriCure Reports Fourth Quarter 2024 and Full Year 2024 Financial Results
|
|
Feb 11
|
Exploring Analyst Estimates for AtriCure (ATRC) Q4 Earnings, Beyond Revenue and EPS
|
|
Oct 8
|
AtriCure to Announce Third Quarter 2024 Financial Results
|
|
Oct 1
|
AtriCure Receives CE-Mark for the EnCompass® Clamp
|
|
Aug 28
|
AtriCure's Shares Likely to Benefit From New AtriClip Device Sales
|
|
Aug 28
|
AtriClip FLEX-Mini device treatment begins with first patient
|
|
Aug 27
|
AtriCure Announces that the First Patient has been Treated with the Revolutionary AtriClip® FLEX-Mini™ Device
|
|
Aug 23
|
AtriCure's (ATRC) AtriClip Receives Expanded CE-Mark Indication
|
|
Jul 29
|
AtriCure to Participate in the Canaccord Genuity 44th Annual Global Growth Conference
|
|
Jul 24
|
AtriCure (ATRC) Gains China Approval for AtriClip LAA System
|
|
Jul 23
|
AtriCure Receives Regulatory Approval to Sell AtriClip® Devices in China
|
|
Jun 27
|
Exploring Three Undervalued Small Caps With Insider Action In The Region
|